Vatorsecurities.se använder sig av cookies för att ge dig som besökare en så bra upplevelse som möjligt.

Equity Research

 

Commissioned research by Vator Securities is offered to selected life science companies – “By Invitation Only”

 

Commissioned Research: Bio-Works Technologies AB

15 April 2019

Bio-Works is a Swedish-based supplier to biopharmaceutical producers, serving early-stage lab-scale to full-scale commercial producers. Its niche is the market for separation media used in protein purification.

The company started commercial sales in 2014. Market demand is driven by increased production volumes of biopharmaceutical products including biosimilars, and productivity investments.

Commissioned research: Immunovia AB

1 April 2019

Immunovia is a Swedish-based diagnostic company in late-stage development for products for early detection of diseases within the oncology and autoimmune areas, with a primary target on early detection of pancreas cancer.

The company’s management team has extensive diagnostics company background, including GE Healthcare and DAKO (aquired by Agilent)

Commissioned research: AlzeCure Pharma

15 January 2019

AlzeCure Pharma is a Swedish-based pharmaceutical company with potentially first-in-class proprietary and novel targeted small molecule (tablets) candidates for neurodegenerative diseases with a primary target on Alzheimer’s Disease (AD).

AlzeCure’s management team has extensive big pharma experience, and formed an integral part of AstraZeneca’s CNS department.